Home > Insider Trading > Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc. (SRPT)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Billionaire Glenn Russell Dubin's 10 Stock Picks with Huge Upside Potential

Glenn Russell Dubin is one of the industry's most experienced hedge fund managers, best known as the co-founder of Highbridge Capital Management, a multi-strategy investment business he founded with Henry...

Keep Reading →

May 10th, 2025 - Hedge Funds Industries News

11 Stocks That Will Bounce Back According to Analysts

Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments.

Keep Reading →

May 8th, 2025 - Hedge Funds Industries News

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2025 Earnings Call Transcript

Operator: Good afternoon, and welcome to the Sarepta Therapeutics First Quarter 2025 Financial Results Conference Call. As a reminder, today's program is being recorded.

Keep Reading →

May 7th, 2025 - News Transcripts

11 Oversold NASDAQ Stocks to Buy Right Now

On April 28, Darrell Cronk, Wells Fargo Wealth and Investment Management CIO, appeared on CNBC's 'Squawk on the Street' to discuss market outlooks and what investors should look at in the current market...

Keep Reading →

April 29th, 2025 - Hedge Funds News

Billionaire George Soros' 10 Small-Cap Stocks with Huge Upside Potential

When a legendary investor like George Soros makes a move, Wall Street pays attention.

Keep Reading →

April 23rd, 2025 - News Stock Analysis

11 Most Promising Long-Term Stocks According to Analysts

On March 31, Banrion's Shana Sissel recently appeared on CNBC's 'Power Lunch' to discuss that buying at lower valuations is favorable for long-term investors.

Keep Reading →

April 21st, 2025 - Hedge Funds News

10 Best Mid Cap Biotech Stocks to Buy

On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.

Keep Reading →

March 26th, 2025 - Hedge Funds Industries News

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2024 Earnings Call Transcript

Operator: Good afternoon. And welcome to the Sarepta Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, today’s program is being recorded.

Keep Reading →

February 27th, 2025 - News Transcripts

15 Stocks That Will Go to The Moon According to Analysts

While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President delayed tariffs on Mexico...

Keep Reading →

February 24th, 2025 - Hedge Funds News

15 Best Fast Growth Stocks To Buy Right Now

In the fourth quarter of 2024, the US Gross Domestic Product (GDP) expanded at an annual rate of 2.3%, slightly below market expectations of 2.7% and a deceleration from the 3.1% growth observed in the...

Keep Reading →

February 20th, 2025 - Hedge Funds News